1. Submission of FDA data in ACE
As discussed in a previous blog post, CBP and FDA are working to implement changes related to FDA’s Final Rule on Submission of Food and Drug Administration Import Data in ACE and corresponding Supplemental Guide. The first deployment occurred on January 5, 2017, and a second is to occur today.
• Invalid state/zip code combination
• Foreign Consignee
• Duplicate Entry
• Missing or incomplete entity address
For specific information related to the various FDA error codes, please refer to FDA’s Error Guide.
3. FDA Requirements Change for Medical Devices, IUC 081.005
The requirements for transmitting medical device constituent parts for drug-device IND combination products, Intended Use Code 081.005 have been changed.
The following Affirmations of Compliance for IUC 081.005 are now conditional: DEV, DFE, LST. These Affirmations of Compliance are in addition to DA and IND, which are already indicated as conditional. This change will be reflected in the next version of FDA’s Supplemental Guide
For questions on any of the foregoing, contact FDA ACE Support
ACE_Support@fda.hhs.gov or 877-345-1101 or 571-620-7320